Amgen (AMGN) Total Debt (2009 - 2026)

Amgen's Total Debt history runs 18 years deep, the most recent figure standing at $57.3 billion for Q1 2026.

• In Q1 2026, Total Debt changed 0.1% year-over-year to $57.3 billion; the TTM figure through Mar 2026 stood at $57.3 billion (changed 0.1% YoY), while the FY2025 annual figure was $54.6 billion, down 9.14% from the prior year.
• Total Debt was $57.3 billion for Q1 2026 at Amgen, up from $54.6 billion in the prior quarter.
• In the past five years, Total Debt ranged from a high of $64.6 billion in Q4 2023 to a low of $36.5 billion in Q2 2022.
• Historically, Total Debt has averaged $54.5 billion across 5 years, with a median of $57.4 billion in 2025.
• The sharpest annual moves came in 2023 and 2025: Total Debt soared 68.51% in 2023, then dropped 10.37% in 2025.
• A 5-year view of Total Debt shows it stood at $38.9 billion in 2022, then jumped by 65.91% to $64.6 billion in 2023, then slipped by 6.99% to $60.1 billion in 2024, then dropped by 9.14% to $54.6 billion in 2025, then gained by 4.98% to $57.3 billion in 2026.
• The last three Total Debt figures came in at $57.3 billion (Q1 2026), $54.6 billion (Q4 2025), and $54.6 billion (Q3 2025), per Business Quant data.